Pharming Group N.V. (PHGUF)
USD 0.84
(0.0%)
USD 0.84
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 56.76 Million USD | 34.1% |
| 2022 | 42.32 Million USD | 55.14% |
| 2021 | 27.28 Million EUR | 28.74% |
| 2020 | 21.19 Million EUR | 30.76% |
| 2019 | 16.2 Million EUR | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 21.99 Million EUR | 16.57% |
| 2016 | 18.86 Million EUR | 6.34% |
| 2015 | 17.74 Million EUR | 8.86% |
| 2014 | 16.29 Million EUR | 147.82% |
| 2013 | 6.57 Million EUR | 136.71% |
| 2012 | 2.77 Million EUR | -67.42% |
| 2011 | 8.52 Million EUR | -28.85% |
| 2010 | 11.98 Million EUR | -25.66% |
| 2009 | 16.12 Million EUR | 5.58% |
| 2008 | 15.27 Million EUR | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 12.1 Million EUR | 165.04% |
| 2005 | 4.56 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 59.15 Million USD | 5.95% |
| 2024 Q3 | 62.22 Million USD | 5.19% |
| 2024 Q1 | 55.83 Million USD | -1.56% |
| 2023 Q1 | 48.12 Million USD | 13.71% |
| 2023 Q3 | 53.43 Million USD | 0.75% |
| 2023 Q2 | 53.04 Million USD | 10.21% |
| 2023 FY | 56.76 Million USD | 34.1% |
| 2023 Q4 | 56.71 Million USD | 6.13% |
| 2022 Q3 | 33.5 Million USD | -1.25% |
| 2022 Q4 | 42.32 Million USD | 26.32% |
| 2022 FY | 42.32 Million USD | 55.14% |
| 2022 Q1 | 29.6 Million USD | 8.46% |
| 2022 Q2 | 33.92 Million USD | 14.6% |
| 2021 Q2 | 24.3 Million EUR | 11.68% |
| 2021 Q3 | 25.07 Million EUR | 3.17% |
| 2021 Q4 | 27.29 Million EUR | 8.85% |
| 2021 FY | 27.28 Million EUR | 28.74% |
| 2021 Q1 | 21.76 Million EUR | 2.87% |
| 2020 Q1 | 16 Million EUR | -1.35% |
| 2020 FY | 21.19 Million EUR | 30.76% |
| 2020 Q4 | 21.15 Million EUR | 10.0% |
| 2020 Q3 | 19.23 Million EUR | 5.41% |
| 2020 Q2 | 18.24 Million EUR | 14.0% |
| 2019 Q4 | 16.22 Million EUR | 25.28% |
| 2019 Q1 | 15.31 Million EUR | -22.77% |
| 2019 Q2 | 14.44 Million EUR | -5.71% |
| 2019 FY | 16.2 Million EUR | 0.0% |
| 2019 Q3 | 12.94 Million EUR | -10.35% |
| 2018 Q3 | 24.34 Million EUR | -9.09% |
| 2018 FY | - USD | -100.0% |
| 2018 Q4 | 19.83 Million USD | -18.52% |
| 2018 Q2 | 26.77 Million EUR | 0.51% |
| 2018 Q1 | 26.64 Million EUR | 21.14% |
| 2017 Q1 | 20.19 Million EUR | 7.05% |
| 2017 FY | 21.99 Million EUR | 16.57% |
| 2017 Q4 | 21.99 Million EUR | 4.1% |
| 2017 Q3 | 21.12 Million EUR | 5.71% |
| 2017 Q2 | 19.98 Million EUR | -1.04% |
| 2016 Q3 | 20.61 Million EUR | -4.26% |
| 2016 Q1 | 20.22 Million EUR | 14.01% |
| 2016 Q2 | 21.53 Million EUR | 6.46% |
| 2016 Q4 | 18.86 Million EUR | -8.49% |
| 2016 FY | 18.86 Million EUR | 6.34% |
| 2015 FY | 17.74 Million EUR | 8.86% |
| 2015 Q3 | 18.76 Million EUR | 14.92% |
| 2015 Q4 | 17.74 Million EUR | -5.44% |
| 2015 Q2 | 16.32 Million EUR | 1.2% |
| 2015 Q1 | 16.13 Million EUR | -1.02% |
| 2014 FY | 16.29 Million EUR | 147.82% |
| 2014 Q4 | 16.29 Million EUR | 39.76% |
| 2014 Q3 | 11.66 Million EUR | 23.28% |
| 2014 Q2 | 9.46 Million EUR | -8.02% |
| 2014 Q1 | 10.28 Million EUR | 56.37% |
| 2013 Q2 | 2.82 Million EUR | -0.61% |
| 2013 Q4 | 6.57 Million EUR | 78.08% |
| 2013 FY | 6.57 Million EUR | 136.71% |
| 2013 Q3 | 3.69 Million EUR | 30.94% |
| 2013 Q1 | 2.83 Million EUR | 2.13% |
| 2012 Q3 | 5.09 Million EUR | 0.0% |
| 2012 Q1 | 9.98 Million EUR | 17.05% |
| 2012 Q4 | 2.77 Million EUR | -45.51% |
| 2012 FY | 2.77 Million EUR | -67.42% |
| 2011 FY | 8.52 Million EUR | -28.85% |
| 2011 Q3 | 9.34 Million EUR | -18.43% |
| 2011 Q1 | 12.55 Million EUR | 4.76% |
| 2011 Q2 | 11.45 Million EUR | -8.77% |
| 2011 Q4 | 8.52 Million EUR | -8.73% |
| 2010 Q2 | 13.65 Million EUR | -9.89% |
| 2010 FY | 11.98 Million EUR | -25.66% |
| 2010 Q1 | 15.15 Million EUR | -6.04% |
| 2010 Q4 | 11.98 Million EUR | -21.38% |
| 2010 Q3 | 15.24 Million EUR | 11.67% |
| 2009 FY | 16.12 Million EUR | 5.58% |
| 2009 Q4 | 16.12 Million EUR | 0.0% |
| 2008 FY | 15.27 Million EUR | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2006 FY | 12.1 Million EUR | 165.04% |
| 2005 FY | 4.56 Million EUR | 0.0% |